172@29@17@102!~!172@29@0@53!~!|news|business|n95-mask-price-rise-manufacturers-blame-supply-crunch-officials-say-no-transparency-report-5811371.html!~!news|moneycontrol|com!~!|controller|infinite_scroll_article.php!~!is_mobile=false
Subscribe to Moneycontrol Pro and grab benefits worth ₹15,000/-
you are here: HomeNewsBusiness
Last Updated : Sep 08, 2020 01:15 PM IST | Source: Moneycontrol.com

N95 mask price rise: Manufacturers blame supply crunch, officials say no transparency: Report

Prices of N95 masks have risen six times since March, when it was sold to the government for Rs 17, to the current Rs 42 while retail price is Rs 150. It is expected to rise again.


Prices of N95 masks used by medical professionals during the COVID-19 pandemic are likely to rise as inventory of raw materials required to make the item dwindles, manufacturers said.

The Centre at present pays Rs 42 per mask, while retail price is Rs 150; and could rise by Rs 10-20 apiece. This comes even as state health department officials raid masks factories as manufacturers “refused to cooperate” on fixed prices.

There is low supply of raw material required to manufacture N95 masks and current stocks are fast declining, India’s biggest mask manufacturers Taloja-based Magnum Health and Safety and Palghar-based Venus Safety told the Mumbai Mirror.

Imported technical textiles is the key raw material for N95 masks, but supplies from Germany and the United States has fallen, leaving them reliant on a single-source alternative – Japan, which will “likely be more expensive,” Mahesh Kudav, director, Venus Safety said, adding that existing stocks will last only 10 days, making the price rise “inevitable.”

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

He, however, pointed out that supplies and stocks of FFP2 masks – an effective alternative to N95 masks are ample and can be used instead. Raw materials for FFP2 masks are made in India and these are thus cheaper at around Rs 18 apiece, Kudav said.

Statements on the prices came as authorities raided Venus’ and Magnum’s factories after the two refused to share details or cost of manufacturing the equipment with the government.

Follow our LIVE Updates on the coronavirus pandemic here

An official told the paper that prices of N95 masks have risen six times since March, when it was sold to the government for Rs 17, to the current Rs 42. They added that manufacturers’ refusal to cooperate has delayed fixing of a price ceiling.

Moneycontrol could not independently verify the report.

“Since the companies refused to share any details with us, we began surveying the factories on Thursday (September 3). We also asked the sales tax department to help us. Both the public health department and sales tax officials are part of the verification drive,” the official said.

The official added that the state had asked the Centre to keep regulating prices of masks and sanitisers but the items were removed from the list in June after which the Maharashtra public health department formed a committee in August.

Follow our full COVID-19 coverage here
First Published on Sep 8, 2020 01:15 pm
Sections